Alexandria, Egypt

Alyaa Adel Ramadan

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Université D'angers. Active years: 2016.


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alyaa Adel Ramadan

Introduction

Alyaa Adel Ramadan is a notable inventor based in Alexandria, Egypt. He has made significant contributions to the field of nanotechnology, particularly in the preparation of lipid nanoparticles. His innovative methods have the potential to advance various applications in medicine and drug delivery.

Latest Patents

Alyaa Adel Ramadan holds a patent for a method of preparing lipid nanoparticles. This method involves creating nanocapsules with a liquid lipid core and a solid shell, which are charged with at least one hydrophilic active agent. The process includes combining microemulsions where the active agent remains in the hydrophilic phase of a first microemulsion and chill-hardening the mixture to obtain the nanocapsules. These nanocapsules consist of a lipid core that is liquid at room temperature, encapsulated in a film that is solid at room temperature. He has 1 patent to his name.

Career Highlights

Throughout his career, Alyaa has worked with esteemed institutions such as Université D'Angers and the National Institute of Health and Medical Research. His work has been instrumental in advancing research in lipid nanoparticles and their applications.

Collaborations

Alyaa has collaborated with notable professionals in his field, including Patrick Saulnier and Jean-Pierre Benoit. These collaborations have further enriched his research and contributions to nanotechnology.

Conclusion

Alyaa Adel Ramadan's innovative work in the preparation of lipid nanoparticles showcases his dedication to advancing scientific research. His contributions are paving the way for future developments in drug delivery systems and nanotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…